CDC grows 2019-nCoV virus in cell culture
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

Filetype[PDF-45.10 KB]


English
Details Related Documents You May Also Like

Details:

  • Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.
  • Description:
    Virus isolates will be used for research by the scientific and medical community

    One important way that CDC is supporting global efforts to study and learn about 2019-nCoV in the laboratory is growing the virus in cell-culture so that researchers in the scientific and medical community can use the virus in their studies.

    - On January 22, 2020, CDC received a clinical specimen collected from the first U.S. patient infected with 2019-nCoV. CDC immediately placed the specimen into cell-culture in order to grow a sufficient amount of virus for study.

    - On February 2, 2020, CDC generated enough 2019-nCoV grown in cell culture to distribute externally.

    - On February 4, 2020, 2019-nCoV was shipped from CDC to the BEI Resources Repository. The BEI Resources Repository is affiliated with the National Institutes of Health (NIH). It is a central repository that supplies organisms and reagents to the broader community of microbiology and infectious disease researchers.

    Once BEI Resourcesexternal icon expands the material that they received from CDC, CDC’s 2019-nCoV isolate can be requested by public and academic institutions that maintain appropriate facilities and safety programs, as well as have the appropriate expertise, as required by BEI. Some areas of 2019-nCoV research that public and academic institutions may study include:

    Antiviral research: This includes research aimed at testing the ability of existing or experimental antiviral medications to treat or prevent infection with 2019-nCoV.

    Pathogenesis research: This includes research to determine the various ways the virus can be transmitted to a host, the severity of illness it causes in a host, how much virus is produced in the body, and what organs the virus can spread to within the body.

    Virus stability research: This is research that indicates how long the virus can survive under certain conditions, such as how long the virus can remain viable and infectious on surfaces, and the temperatures at which it can survive.

  • Subjects:
  • Series:
    2019 novel coronavirus
  • Document Type:
    Webpage
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

Related Documents

You May Also Like

Checkout today's featured content at stacks.cdc.gov